tradmap

INBS Earnings INTELLIGENT BIO SOLUTIONS INC.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$127 -$64 $0 2022 2023 2024 2025 2026
EPS
Revenue (annual)
$0 $2M $4M 2020 2021 2022 2023 2024 2025 2026
Revenue
Net income (annual)
-$12M -$6M $0 2020 2021 2022 2023 2024 2025 2026
Net income

Quarterly results

Diluted EPS (quarterly)
-$104 -$52 $0 Q3 '22 Q1 '23 Q4 '23 Q3 '24 Q1 '25 Q4 '25
EPS
Revenue (quarterly)
$0 $572901 $1M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$4M -$2M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–17 of 17
FY 20262026-06-30-8.442026-08-1910-K
Q3 20262026-03-31-7.542026-05-1310-Q
Q2 20262025-12-31-6.272026-02-1210-Q
Q1 20262025-09-30-0.352025-11-1210-Q
FY 20262025-06-30-20.042026-08-1910-K
Q3 20262025-03-31-15.922026-05-1310-Q
Q2 20262024-12-31-11.822026-02-1210-Q
Q1 20262024-09-30-0.702025-11-1210-Q
FY 20252024-06-30-6.382025-08-1510-K
Q3 20252024-03-31-6.642025-05-1310-Q
Q2 20252023-12-31-7.682025-02-1310-Q
Q1 20252023-09-30-12.482024-11-0710-Q
FY 20242023-06-30-127.002024-09-1810-K
Q3 20242023-03-31-104.042024-05-0810-Q
Q2 20242022-12-31-23.652024-02-0910-Q
Q1 20242022-09-30-1.622023-11-0810-Q
FY 20232022-06-30-11.332023-08-2310-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.